We’re proud to share that ReNewVax CEO, Neil Murray, had his article published in Pharmaphorum, addressing one of the most urgent global health challenges of our time, antimicrobial resistance (AMR). Titled “When is the superbug message going to bite?”, the article...
ReNewVax are pleased to announce the appointment of Simon Thorn as Chief Financial Officer. An accomplished senior executive with significant expertise in the venture capital sector working hands-on with SME’s to help them to scale, prior to joining ReNewVax, Simon...
ReNewVax has been included in the “Northern Life Sciences” supplement published by City AM. The supplement shines a spotlight on the achievements of the sector in the North, with features on this year’s Bionow Award winners and the important role that Bionow...
We were delighted to receive the award for Start-up of the year at last night’s Annual Bionow Awards Dinner. Commenting on the award, Neil Murray, ReNewVax’s CEO, said, “It’s a great honour to receive the Bionow Start-up of the Year Award. This is testament to the...
ReNewVax are pleased to announce the appointment of Dr Miguel Leon-Rios as Head of Research. An experienced immunologist, Miguel has been intimately involved in the translational development of our lead program RVX-001, both during his time at the University of...
